Laekna, a global biotechnology company specializing in metabolic and cancer drug development, has partnered with Eli Lilly and Company...

Forte Biosciences, Inc., a clinical-stage biopharmaceutical company specializing in autoimmune and related diseases, has raised $53 million in an...

Puma Biotechnology initiated its ALISertib in CAncer (ALISCA™-Breast1) Phase II trial (PUMA-ALI-1201; NCT06369285). This trial investigates alisertib combined with...

COTA, Inc., a real-world data (RWD) and analytics company specializing in oncology, and Memorial Sloan Kettering Cancer Center (MSK)...

Glox Therapeutics, a company developing precision antibiotic therapies using naturally occurring bacteriocins, has received £1 million in grant funding...

Pfizer has appointed Chris Boshoff, M.D., PhD, as its new Chief Scientific Officer and President of Research & Development,...

The National Ataxia Foundation (NAF) recently collaborated with members of Congress to conduct an informational meeting about Spinocerebellar Ataxia...

Immunis, Inc., a clinical-stage biotechnology company, has successfully completed a Phase 1/2a clinical trial of IMM01-STEM, a novel multi-active...

Asimov, a synthetic biology company focused on therapeutic design and manufacturing, has entered into a licensing agreement with RevOpsis...

Steritas LLC, a company focused on improving care for patients treated with steroids, has partnered with global immunology company...